ADIPOQ and metabolic syndrome: The metabolic syndrome has a negative relationship between adiponectin and inflammatory markers, such as TNF-α, IL-6, and CRP, possibly due to the anti-inflammatory effects of adiponectin [98] (Fig. 2).